Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn ASH Highlights on CAR-T & Bispecific Antibodies for iNHL: Are Axi-Cel/Tisa-Cel Effective in FL & MZ? How Beneficial Are Mosunetuzumab/Odronextamab in R/R FL?
Comments 0
Login to view comments.
Click here to Login
